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Abstract Myopia is a complex genetic disorder and a
common cause of visual impairment among working age
adults. Genome-wide association studies have identified
susceptibility loci on chromosomes 15q14 and 15q25 in
Caucasian populations of European ancestry. Here, we
present a confirmation and meta-analysis study in which
we assessed whether these two loci are also associated with
myopia in other populations. The study population com-
prised 31 cohorts from the Consortium of Refractive Error
and Myopia (CREAM) representing 4 different continents
with 55,177 individuals; 42,845 Caucasians and 12,332
Asians. We performed a meta-analysis of 14 single
nucleotide polymorphisms (SNPs) on 15q14 and 5 SNPs on
15q25 using linear regression analysis with spherical
equivalent as a quantitative outcome, adjusted for age and
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sex. We calculated the odds ratio (OR) of myopia versus
hyperopia for carriers of the top-SNP alleles using a fixed
effects meta-analysis. At locus 15q14, all SNPs were sig-
nificantly replicated, with the lowest P value 3.87 9 10-12
for SNP rs634990 in Caucasians, and 9.65 9 10-4 for
rs8032019 in Asians. The overall meta-analysis provided
P value 9.20 9 10-23 for the top SNP rs634990. The risk
of myopia versus hyperopia was OR 1.88 (95 % CI 1.64,
2.16, P \ 0.001) for homozygous carriers of the risk allele
at the top SNP rs634990, and OR 1.33 (95 % CI 1.19, 1.49,
P \ 0.001) for heterozygous carriers. SNPs at locus 15q25
did not replicate significantly (P value 5.81 9 10-2 for top
SNP rs939661). We conclude that common variants at
chromosome 15q14 influence susceptibility for myopia in
Caucasian and Asian populations world-wide.
Introduction
Refractive errors are common optical defects of the visual
system. An important refractive error is myopia (near-
sightedness), which occurs when the eye elongates beyond
the focal plane. The prevalence of myopia is high, affecting
about one-third of the world’s population, and reaching
over 70 % in certain Asian ethnic groups (He et al. 2004;
Kempen et al. 2004; Lin et al. 2004; Vitale et al. 2008; Wu
et al. 2001). High degrees of myopia are associated with
pathologic ocular changes, such as myopic macular
degeneration, retinal detachment, and glaucoma (Curtin
and Karlin 1971; McBrien and Gentle 2003; Saw 2006;
Saw et al. 2005; Tano 2002). Due to the limited treatment
options, myopia is a common cause of visual impairment
(Tano 2002; Young 2009).
Refractive errors, and myopia in particular, are complex
genetic traits with a largely unknown etiology. Established
environmental factors are education, early reading, and
reduced outdoor exposure (Dirani et al. 2009; Ip et al. 2008;
McBrien et al. 2008; Morgan and Rose 2005; Rose et al. 2008;
Saw et al. 2001; Young 2009). Although heritability estimates
are high [50–90 % (Young et al. 2007)], the search for myopia
genes is still ongoing. Previous linkage and association studies
have led to the identification of at least 18 myopia (MYP) loci,
10 additional chromosomal regions, and several candidate
genes (Baird et al. 2010; Young 2009). Replication of these
associations has been inconsistent, and their application to the
general population is limited (Baird et al. 2010).
Recent genome-wide association studies (GWAS)
reported several susceptibility loci for refractive error and
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myopia (Hysi et al. 2010; Li et al. 2011a, b; Nakanishi
et al. 2009; Shi et al. 2011; Solouki et al. 2010). Solouki
et al. (2010) and Hysi et al. (2010) were the first to perform
a GWAS in a general Caucasian population, and identified
susceptibility loci on chromosomes 15q14 and 15q25,
respectively. In both studies, carriers of single nucleotide
polymorphism (SNP) rs634990 at 15q14 (OR 1.83, 95 %
CI 1.42–2.36) and of SNP rs8027411 at 15q25 (OR 1.16,
95 % CI 1.02–1.28) had a higher risk of myopia. Confir-
mation of these findings was obtained in various replication
studies (Hayashi et al. 2011; Hysi et al. 2010; Solouki et al.
2010). However, these replication cohorts were relatively
limited in size, increasing the chance of a type 1 error.
To address potential inaccuracies and to investigate gener-
alizability, we investigated the associations between refractive
error, and the 15q14 and 15q25 susceptibility loci in a large
international replication and meta-analysis study (Consortium
of Refractive Error and Myopia, CREAM) including 31
cohorts with various ethnicities from 4 different continents.
Results
Meta-analysis of allelic effects on spherical
equivalent (SE)
Complete data on refractive error and genome-wide SNPs
were available in all 29 population-based studies com-
prising 49,364 subjects: 42,224 Caucasians and 7,140
Asians (Table 1; Fig. 1, Supplementary Table 1). This
includes the previously reported discovery set consisting of
15,608 (Solouki et al. 2010) and 17,608 subjects (Hysi
et al. 2010), respectively.
Table 2 shows the results of the meta-analysis of the 14
SNPs (Hysi et al. 2010; Solouki et al. 2010) at locus 15q14
and 5 SNPs at locus 15q25. The frequency of the effect
allele C for top SNP rs634990 at locus 15q14 ranged from
0.38 to 0.64, while frequency of the effect allele A for top
SNP rs939661 at 15q25 showed a larger variation, ranging
from 0.28 to 0.63 (Supplementary Figure 1). The sample
size of each SNP per study is provided in Supplementary
Table 1. For locus 15q14, the magnitude and direction of
the effects were consistent in all cohorts except Croatia Vis
and SIMES. For locus 15q25, there was less consistency;
for top SNP rs939661 8 cohorts—both Caucasian and
Asian (Australian Twins, Croatia Split, Croatia Vis,
EGCUT, FITSA, GHS II, ORCADES, and SIMES)—had
a regression beta coefficient in the opposite direction to
that of the other studies.
For locus 15q14, the replication set, consisting of all
studies except the ones previously used in the discovery
analysis, showed a statistically significant association
between SE and all SNPs with a best P value 4.53 9 10-14
for top SNP rs634990. Confirmation was achieved in 23
out of 25 Caucasian studies (overall P 3.87 9 10-12 for
SNP rs634990), and in 3 out of 4 Asian studies (overall
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P 2.21 9 10-3 for SNP rs634990). Meta-analysis of the
discovery and replication cohorts together provided
P value 9.20 9 10-23 for SNP rs634990.
For locus 15q25, neither Caucasian nor Asian validation
studies replicated the original association. Meta-analysis of
the combined set of the 5 SNPs yielded a lowest
P 1.22 9 10-4 for SNP rs939661. As a subsequent analysis,
we investigated locus 15q25 in more detail, and tested another
26 SNPs in 26 out of 29 cohorts (no data available in
ALSPAC, AREDS 1, and EGCUT). This set of SNPs was not
replicated either, however, meta-analysis including the dis-
covery cohort was still significant (best P 2.07 9 10-4 for
SNP rs1915726; Supplementary Table 3).
Meta-analysis of risk of myopia for top SNP
Genotype distributions for rs634990 at locus 15q14 were
available for 28 out of 31 studies (all but FITSA, Australian
Twins, and SORBS). There was no evidence of heteroge-
neity in the analyses of homozygote carriers [v2 21.35 (d.f.
26), P 0.724, I2 0.0 %] or heterozygote carriers [v2 24.22
(d.f. 26), P 0.564, I2 0.0 %]. Therefore, only results from
fixed effects meta-analysis were used. Figure 2 shows the
forest plots for the risk of myopia for homozygous and
heterozygous carriers of the top SNP rs634990. The OR of
moderate to high myopia (SE B-3 D) versus moderate to
high hyperopia (SE C?3 D) was 1.88 (95 % CI 1.64, 2.16,
P \ 0.001) for homozygous carriers of the risk allele at the
top SNP rs634990, and 1.33 (95 % CI 1.19, 1.49,
P \ 0.001) for heterozygous carriers.
Discussion
Chromosome 15q was first implicated in refractive error
and myopia by genome-wide analysis of two large studies
located in Northern Europe (Hysi et al. 2010; Solouki et al.
2010). Here, in an international meta-analysis consisting of
31 independent studies from the CREAM consortium, we
provide further support that the association with locus
15q14 is robust and present in both Caucasians and Asians.
We combined the results with those of the initial study into
a powerful meta-analysis of highly associated SNPs with a
total study population of 55,177 participants. The com-
bined results showed that all tested SNPs for locus 15q14
were associated with refractive errors, and that homozy-
gous carriers of the top SNP rs634990 had approximately
twice the risk of myopia. SNPs at the other locus, 15q25,
could not be convincingly replicated.
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This study has strengths and limitations. Major strengths
of the study include the sample size and the inclusion of
different ethnicities. The CREAM consortium represents
the largest study on refractive error known to date. Previ-
ous replication studies have not been large scaled and
focused on populations of the same ancestry (Gao et al.
2012; Lu et al. 2011; Wang et al. 2011). Another advantage
of our study is the incorporation of clinical relevant end-
points such as high myopia and high hyperopia. Among the
limitations are differences in designs and methods of the
studies. (1) Population-based as well as case control studies
were incorporated. However, the latter were only two
(Kyoto Study and SORBS) and both had results within the
same range as the population-based studies. (2) Different
types of equipment and measurement methods were used to
detect refractive error. These differences are generally
subtle, and are not likely to cause false findings. (3) Var-
ious methods of genotyping and imputation were used, and
genotyping was not complete in all studies. All SNPs at
15q14 had similar effect; thus, we do not think this has
influenced these associations. SNPs at 15q25 showed larger
variation, and the incomplete genotyping may have
underpowered this analysis.
Earlier replication of the 15q14 locus was reported by
Hayashi et al. (2011) in a Japanese sample of high myopic
probands and controls. In a comparison of 1,125 high
myopes (axial length[26.1 mm) versus 1,295 controls, the
risk of high myopia was increased for the carriers of the
initial top SNP rs634990 [OR 1.84 in homozygotes (95 %
CI 1.44–2.36)]. Taken together with the current findings,
this suggests that 15q14 plays a role in both common and
high myopia.
The 15q14 associated region contains two interesting
genes that are both well expressed in the retina, GJD2 and
ACTC1. GJD2 encodes the Connexin36 protein, which
plays a crucial role in the transmission and processing of
visual signals in the retina by enabling intercellular trans-
port of small molecules and ions in photoreceptors, ama-
crine and bipolar cells (Deans et al. 2002; Guldenagel et al.
2001; Kihara et al. 2009; Striedinger et al. 2005). We
speculated that the protein encoded by the other candidate
gene, ACTC1, could play a role in scleral remodeling,
given the fact that similar actin proteins have been shown
to be increased in developing myopic tree shrew eyes
(Jobling et al. 2009). Previous GJD2 (Solouki et al. 2010)
and ACTC1 (unpublished data) direct sequencing experi-
ments did not reveal a functional variant, but the 15q14
locus appeared to harbor regulatory elements which may
influence transcription of these genes (Solouki et al. 2010).
The 15q25 region contains the interesting candidate
gene RASGRF1, which is highly expressed in the retina and
has previously been implicated in photoreception and
visual sensory processes (Fernandez-Medarde et al. 2009;
Jones and Moses 2004). The association with this locus and
gene is not robust, since none of the initial SNPs replicated
significantly, and determination of more SNPs did not
increase significance. A type 1 error may explain the initial
finding. Another potential cause for the non-replication is a
large variation in allele frequencies. The range of allele
frequencies at 15q25 (0.28–0.63) was only slightly larger
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than at 15q14 (0.38–0.64) in our consortium, making this
an unlikely explanation (Supplementary Figure 1). Finally,
population stratification within cohorts did not appear to
play a major role, since only two cohorts had significant
principal components, which were addressed in the
analyses.
Other GWAS loci were only found for high myopia in
Asian case control studies, and they were located on
chromosomes 11q24.1 (Nakanishi et al. 2009), 5p15 (Li
et al. 2011a), 4q25 (Li et al. 2011b), and 13q12.12 (Shi
et al. 2011). The locus on chromosome 5p15 harbors the
excellent candidate gene CTNND2 which is involved in
retinal morphogenesis, adhesion, retinal cell architecture
integrity (Duparc et al. 2006; Paffenholz et al. 1999), and
was replicated in subjects of the same ethnicity (Lu et al.
2011). Replication studies for the 4q25 (Gao et al. 2012)
and 11q24.1 (Wang et al. 2011) loci were only successful
in case of the 4q25 locus; these loci did not have prominent
candidate genes.
What should be the next steps? For 15q14, compre-
hensive resequencing of the entire associated region and
the flanking genes can reveal the responsible gene
Table 1 Descriptives of all study cohorts
Study n Mean age (SD) Age range Men (%) Mean SE (SD)
1958 British Birth Cohort 1,658 42 (0.0) 40–50 54.2 -0.96 (2.00)
AGES Reykjavik 2,986 76.3 (5.4) 60–80? 35.3 1.22 (2.05)
ALSPAC 3,804 15.4 (0.3) 14.25–17.08 47.2 -0.38 (1.28)
AREDS 1 816 79.5 (5.1) 60–80? 43.5 0.68 (1.94)
AREDS 2 1,506 68.0 (4.7) 55–81 41.1 0.54 (2.25)
Australian Twins 1,819 22.2 (12.7) 5–90 44.0 -0.22 (1.28)
Blue Mountains Eye Study 1,574 64 (7.9) 50–80? 43.4 0.59 (1.96)
Croatia Split 366 49.8 (14.4) 18–85 46.0 -1.83 (1.83)
Croatia Vis Island 544 55.8 (14.0) 18–83 40.0 -0.16 (1.93)
Croatia Korcula Island 836 56.0 (13.8) 18–98 35.0 -0.25 (1.92)
ERF 2,032 48.5 (14.3) 18? 43.1 0.07 (2.13)
EGCUT 338 34.8 (15.2) 18–85 36.9 -2.60 (2.00)
Finnish Twin Study on Aging 127 68.2 (3.8) 63–76 0.0 1.68 (1.54)
Framingham Eye Study 1,500 55.5 (9.0) 20–80 42.5 -0.17 (2.40)
Gutenberg Health Study I 2,745 55.7 (11) 35–74 51.5 -0.38 (2.44)
Gutenberg Health Study II 1,142 55.0 (10.9) 35–74 49.8 -0.41 (2.58)
KORA 1,867 55.6 (11.7) 35–84 49.6 -0.29 (2.27)
MESA 1,462 62 (9.4) 46–86 49.5 -0.28 (2.62)
ORCADES 505 54.8 (13.7) 22–88.5 43.0 0.01 (2.14)
Rotterdam Study 1 5,328 68.5 (8.6) 55? 41.3 0.86 (2.45)
Rotterdam Study 2 2,009 64.2 (7.4) 55? 45.9 0.48 (2.51)
Rotterdam Study 3 1,970 56.0 (5.5) 45? 43.9 -0.35 (2.62)
OGP Talana 623 44.5 (21.1) 5–89 51.8 -0.15 (1.78)
SCORM 929 10.8 (0.8) 10–15 48.0 -2.02 (2.26)
SiMES 2,226 57.7 (10.8) 40–80 49.3 -0.08 (1.98)
SINDI 2,055 55.7 (8.7) 40–80? 51.2 0.01 (2.13)
SP2 1,930 47.5 (10.9) 20–80 45.4 -1.67 (2.89)
TwinsUK 4,270 55.0 (12.0) 20–82 7.4 -0.39 (2.73)
Young Finns 397 37.6 (5.2) 25–50 45.0 -1.20 (2.29)
Kyoto Study 5,192 na na na na
Cases 1,143 58.4 (14.3) 20–91 33.3 -10.50 (6.44)
Controls 1 3,120 58.5 (13.6) 20–90 61.7 na
Controls 2 929 38.8 (11.8) 0–74 41.3 na
SORBS 621 na na na na
Cases 100 45.4 (6.6) 18–40 36.4 na
Controls 521 28.3 (15.16) 18–80 45.0 na
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defects which determine the association. Novel tech-
niques such as next-generation sequencing are promising
in this regard. Functional studies in knockout animals
will shed light on potential protein effects. Finally,
evaluation of gene-environment interactions may explain
phenotypic variation and help identify high risk groups.
For myopia genetics in general, performance of a gen-
ome-wide meta-analysis is a logical next step. The cur-
rent CREAM collaboration is an excellent platform for
this project.
In summary, we have convincingly demonstrated that
common variants at chromosome 15q14 influence suscepti-
bility for myopia in both Caucasian and Asian populations
around the world. Identification of functional variants and
responsible genes that explain this association will provide
more insight in the complex etiology of myopia.
Materials and methods
Subjects and phenotyping
A total of 31 study cohorts from the Consortium of Refrac-
tive Error and Myopia (CREAM) participated in this meta-
analysis. 29 population-based as well as 2 case–control
studies were included. General methods, descriptives and
phenotyping and genotyping methods of the study cohorts
can be found in Table 1, the Supplementary Material and
Supplementary Table 1, respectively. In short, 22 cohorts
consisted of Caucasian, and 5 of Asian study subjects. All
studies were performed with the approval of their local
Medical Ethics Committee, and written informed consent
was obtained from all participants in accordance with the
Declaration of Helsinki.
Fig. 1 Mean age and distribution of spherical equivalent in all study cohorts
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Table 2 Meta-analysis of allelic effects on spherical equivalent at locus 15q14 and 15q25
SNP Position Effect allele Non effect allele Freq. Discovery (n = 15,608)a Replication (n = 33,755)b Caucasian (n = 26,615)c
beta se P beta se P beta se P
Locus 15q14
rs634990 32793365 C T 0.49 -0.23 0.03 1.35 x 10-14 -0.09 0.01 4.53 x 10-14 -0.08 0.01 3.87 x 10-12
rs560766 32788234 A G 0.48 -0.20 0.03 4.82 x 10-12 -0.09 0.01 3.53 x 10-14 -0.08 0.01 3.91 x 10-12
rs524952 32793178 A T 0.48 -0.23 0.03 1.19 x 10-14 -0.08 0.01 9.05 x 10-13 -0.08 0.01 1.07 x 10-11
rs688220 32786167 A G 0.48 -0.20 0.03 4.43 x 10-12 -0.08 0.01 1.01 x 10-13 -0.08 0.01 1.38 x 10-11
rs580839 32786121 A G 0.48 -0.20 0.03 4.39 x 10-12 -0.08 0.01 1.05 x 10-13 -0.08 0.01 1.34 x 10-11
rs11073060 32777143 A C 0.48 -0.21 0.03 1.12 x 10-12 -0.08 0.01 2.46 x 10-13 -0.08 0.01 2.47 x 10-11
rs4924134 32781857 G A 0.45 -0.21 0.03 1.20 x 10-12 -0.08 0.01 3.01 x 10-13 -0.08 0.01 2.96 x 10-11
rs7176510 32786771 T C 0.45 -0.20 0.03 1.70 x 10-11 -0.09 0.01 8.31 x 10-14 -0.08 0.01 7.81 x 10-12
rs619788 32782398 A C 0.44 -0.20 0.03 3.94 x 10-12 -0.08 0.01 2.21 x 10-13 -0.08 0.01 2.29 x 10-11
rs7163001 32777866 A G 0.44 -0.21 0.03 1.26 x 10-12 -0.08 0.01 6.28 x 10-13 -0.08 0.01 4.16 x 10-11
rs11073059 32776966 A T 0.44 -0.21 0.03 1.98 x 10-12 -0.08 0.01 8.78 x 10-13 -0.08 0.01 4.85 x 10-11
rs11073058 32776918 T G 0.44 -0.20 0.03 2.23 x 10-12 -0.08 0.01 8.52 x 10-13 -0.08 0.01 4.84 x 10-11
rs685352 32795627 G A 0.46 -0.21 0.03 4.55 x 10-13 -0.08 0.01 4.32 x 10-12 -0.08 0.01 2.09 x 10-10
rs8032019 32778782 G A 0.40 -0.19 0.03 1.00 x 10-10 -0.08 0.01 5.81 x 10-12 -0.08 0.01 7.00 x 10-10
SNP Position Effect allele Non effect allele Freq. Discovery (n = 17,806)a Replication (n = 31,557)b Caucasian (n = 24,417)c
beta se P beta se P beta se P
Locus 15q25
rs939661 77218118 A G 0.51 -0.15 0.03 3.85 x 10-9 -0.02 0.01 5.81 x 10-2 -0.02 0.01 7.73 x 10-2
rs939658 77238924 G A 0.51 -0.15 0.03 1.85 x 10-9 -0.02 0.01 1.60 x 10-1 -0.02 0.01 2.16 x 10-1
rs17175798 77251015 C T 0.51 -0.15 0.03 1.99 x 10-9 -0.02 0.01 1.81 x 10-1 -0.01 0.01 2.38 x 10-1
rs8033963 77242405 C C 0.51 -0.15 0.03 1.86 x 10-9 -0.01 0.01 2.18 x 10-1 -0.02 0.01 2.20 x 10-1
rs8027411 77248084 T G 0.51 -0.15 0.03 2.07 x 10-9 -0.01 0.01 2.49 x 10-1 -0.02 0.01 2.16 x 10-1
SNP Position Effect allele Non effect allele Freq. Asian (n = 7,140)d Meta-analysis (n = 49,363)e
beta se P beta se P
Locus 15q14
rs634990 32793365 C T 0.49 -0.12 0.04 2.21 x 10-3 -0.11 0.01 9.20 x 10-3
rs560766 32788234 A G 0.48 -0.12 0.04 1.47 x 10-3 -0.10 0.01 1.03 x 10-21
rs524952 32793178 A T 0.48 -0.18 0.07 9.52 x 10-3 -0.10 0.01 2.00 x 10-21
rs688220 32786167 A G 0.48 -0.12 0.04 9.80 x 10-4 -0.10 0.01 3.44 x 10-21
rs580839 32786121 A G 0.48 -0.12 0.04 1.10 x 10-3 -0.10 0.01 3.51 x 10-21
rs11073060 32777143 A C 0.48 -0.12 0.04 1.45 x 10-3 -0.10 0.01 5.13 x 10-21
rs4924134 32781857 G A 0.45 -0.12 0.04 1.60 x 10-3 -0.10 0.01 5.57 x 10-21
rs7176510 32786771 T C 0.45 -0.12 0.04 1.74 x 10-3 -0.10 0.01 6.09 x 10-21
rs619788 32782398 A C 0.44 -0.12 0.04 1.54 x 10-3 -0.10 0.01 6.97 x 10-21
rs7163001 32777866 A G 0.44 -0.11 0.04 2.81 x 10-3 -0.10 0.01 1.41 x 10-20
rs11073059 32776966 A T 0.44 -0.11 0.04 3.64 x 10-3 -0.10 0.01 2.63 x 10-20
rs11073058 32776918 T G 0.44 -0.11 0.04 3.50 x 10-3 -0.10 0.01 2.68 x 10-20
rs685352 32795627 G A 0.46 -0.11 0.04 4.14 x 10-3 -0.10 0.01 8.10 x 10-20
rs8032019 32778782 G A 0.40 -0.13 0.04 9.65 x 10-4 -0.10 0.01 1.78 x 10-18
Locus 15q25
rs939661 77218118 A G 0.51 -0.03 0.04 4.86 x 10-1 -0.04 0.01 1.22 x 10-4
rs939658 77238924 G A 0.51 -0.04 0.05 3.94 x 10-1 -0.04 0.01 4.32 x 10-4
rs17175798 77251015 C T 0.51 -0.05 0.06 3.70 x 10-1 -0.04 0.01 6.12 x 10-4
Hum Genet
123
All studies used a similar protocol for phenotyping. Exclu-
sion criteria were age B10 years, and bilateral cataract surgery,
laser refractive procedures or other intra-ocular procedures
which might alter refraction. Eligible participants underwent a
complete ophthalmologic examination including a non-dilated
measurement of refractive error (Table 1) of both eyes.
Spherical equivalent was calculated according to the standard
formula (SE = sphere ?  cylinder), and the mean of two
eyes was used for analysis. When data from only one eye were
available, the SE of this eye was used. SE was categorized into
low (SE from -1.5 to -3 D), moderate (SE from -3 to -6 D)
and high (SE of -6 D or lower) myopia; and also into low (SE
from ?1.5 to ?3 D), moderate (SE from ?3 to ?6 D) and high
(SE of ?6 D or higher) hyperopia. Emmetropia was defined as
SE equal to or between -1.5 and ?1.5 D.
Genotyping and imputation
DNA was extracted according to standard procedures, and
genotyping and imputation of SNPs across the entire gen-
ome was performed using various methods (Table 1).
Samples with a low call rate, with excess autosomal het-
erozygosity, with sex-mismatch, or outliers identified by
the identity-by-state clustering analysis were excluded.
Statistical analysis
Meta-analysis of allelic effects on spherical equivalent
We selected 19 SNPs within loci 15q14 (14 SNPs) and
15q25 (5 SNPs) with a P value of\10-6 from two previous
GWAS (Hysi et al. 2010; Solouki et al. 2010). Linear
regression models with a 1 degree of freedom trend test
were used to examine associations with SE as a quantita-
tive trait outcome, adjusting for age and gender and sig-
nificant principal components if applicable. From all
population-based cohorts, we obtained effect allele, non
effect allele, regression coefficient beta, standard error,
P value, minor allele and minor allele frequency for each of
these SNPs. METAL for Linux was used to perform a
meta-analysis on betas and standard errors for all SNPs.
First, discovery cohorts (Hysi et al. 2010; Solouki et al.
2010) and replication studies were analyzed separately,
followed by a combined meta-analysis. As a second anal-
ysis, 26 additional SNPs within the same linkage disequi-
librium (LD) block were selected and tested for association
using the procedures mentioned above. For these analyses,
Bonferroni corrected P values (0.05/number of tested
SNPs) of 3.57 9 10-3 for 15q14, and 1.0 9 10-2 (5 SNPs,
Table 2) or 1.92 9 10-3 (26 SNPs, Table 3 Supplementary
Material) for 15q25 were considered statistically
significant.
Meta-analysis of risk of myopia for top SNP
From all population-based and case control studies, we
obtained genotype distributions of the replicated top SNPs.
We calculated heterogeneity (v2, I2 calculated and corre-
sponding P values) between studies, crude OR with cor-
responding 95 % CI and P value of moderate and high
myopia versus moderate and high hyperopia with a random
as well as fixed effects meta-analysis using Stata 11. When
these analyses provided similar outcomes, data from fixed
effect analysis were used. For studies without subjects with
high or moderate hyperopia, emmetropia was used as a
Table 2 continued
SNP Position Effect allele Non effect allele Freq. Asian (n = 7,140)d Meta-analysis (n = 49,363)e
beta se P beta se P
rs8033963 77242405 C C 0.51 -0.01 0.04 8.42 x 10-1 -0.04 0.01 9.37 x 10-4
rs8027411 77248084 T G 0.51 0.00 0.04 9.12 x 10-1 -0.03 0.01 1.14 x 10-3
Freq average frequency
a For the 15q14 locus: RS1, RS2, RS3, ERF, TwinsUK; for the 15q25 locus: TwinsUK, RS1, RS2, RS3, ERF, 1958 British Birth Cohort, Australian Twins (adult samples only)
b For the 15q14 locus: 1958 British Birth Cohort, AGES, ALSPAC, AREDS 1, AREDS 2, Australian Twins, BMES, Croatia Split, Croatia Vis, Croatia Korcula, EGCUT,
FITSA, Framingham, GHS I, GHS II, KORA, MESA, ORCADES, OGP Talana, SCORM, SiMES, SINDI, SP2, Young Finns; for the 15q25 locus: AGES, ALSPAC, AREDS 1,
AREDS 2, BMES, Croatia Split, Croatia Vis, Croatia Korcula, EGCUT, FITSA, Framingham, GHS I, GHS II, KORA, MESA, ORCADES, OGP Talana, Young Finns,
SCORM, SiMES, SINDI, SP2
c For the 15q14 locus: 1958 British Birth Cohort, AGES, ALSPAC, AREDS 1, AREDS 2, Australian Twins, BMES, Croatia Split, Croatia Vis, Croatia Korcula, EGCUT,
FITSA, Framingham, GHS I, GHS II, KORA, MESA, ORCADES, OGP Talana, Young Finns; for 15q25 locus: AGES, ALSPAC, AREDS 1, AREDS 2, BMES, Croatia Split,
Croatia Vis, Croatia Korcula, EGCUT, FITSA, Framingham, GHS I, GHS II, KORA, MESA, ORCADES, OGP Talana, Young Finns
d Asian replication: SP2, SIMES, SINDI, SCORM
e All studies
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Fig. 2 Forest plots of odds ratios of myopia (spherical equivalent
B-3 diopters) versus hyperopia (spherical equivalent C?3 diopters)
for top SNP rs634990. *For studies without subjects with high or
moderate hyperopia, emmetropia was used as a reference group.
a Homozygotes carriers of alleles TT versus CC for SNP rs634990.
b Heterozygotes carriers of alleles TT versus TC for SNP rs634990
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reference group. A standard P value of \0.05 was con-
sidered statistically significant.
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